- Report
- December 2024
- 150 Pages
Global
From €2961EUR$3,358USD£2,563GBP
€3484EUR$3,950USD£3,016GBP
- Report
- September 2025
- 369 Pages
Global
From €5159EUR$5,850USD£4,466GBP
- Report
- September 2025
- 176 Pages
Global
From €5159EUR$5,850USD£4,466GBP
- Report
- July 2025
- 350 Pages
Global
From €4365EUR$4,949USD£3,778GBP
- Report
- June 2025
- 400 Pages
Global
From €4365EUR$4,949USD£3,778GBP
- Report
- June 2025
- 200 Pages
Global
From €2460EUR$2,789USD£2,129GBP
- Report
- June 2025
- 150 Pages
Global
From €2380EUR$2,699USD£2,061GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2460EUR$2,789USD£2,129GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2460EUR$2,789USD£2,129GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2460EUR$2,789USD£2,129GBP
- Report
- June 2025
- 200 Pages
Global
From €2460EUR$2,789USD£2,129GBP
- Report
- June 2025
- 200 Pages
Global
From €2460EUR$2,789USD£2,129GBP
- Report
- February 2025
- 60 Pages
Global
From €8815EUR$9,995USD£7,631GBP
- Report
- August 2025
- 150 Pages
Global
From €3395EUR$3,850USD£2,939GBP
- Report
- November 2024
- 120 Pages
Latin America
From €5247EUR$5,950USD£4,543GBP
- Report
- June 2025
- 200 Pages
United States
From €2196EUR$2,490USD£1,901GBP
- Report
- July 2025
- 60 Pages
Europe
From €2866EUR$3,250USD£2,481GBP
- Report
- June 2025
- 143 Pages
United States
From €3174EUR$3,599USD£2,748GBP
- Report
- November 2024
- 91 Pages
Europe
From €1323EUR$1,500USD£1,145GBP
- Report
- September 2023
- 150 Pages
Global
From €3969EUR$4,500USD£3,436GBP

Cannabidiol (CBD) is a cannabinoid found in the Cannabis sativa plant. It is a non-psychoactive compound that has been studied for its potential therapeutic effects on the central nervous system (CNS). CBD has been found to have anti-inflammatory, antioxidant, and neuroprotective properties, and has been studied for its potential to treat a variety of neurological disorders, including epilepsy, anxiety, depression, and Parkinson's disease.
CBD is increasingly being used as an alternative to traditional CNS drugs, such as benzodiazepines and opioids. It is being studied for its potential to reduce the side effects of traditional medications, as well as its potential to treat a variety of neurological conditions.
The CBD market is growing rapidly, with a variety of products available, including oils, tinctures, edibles, and topical creams. Companies in the market include Charlotte's Web, Elixinol, and Endoca. Show Less Read more